Grifols SA

GRFS · BOLSA

$7.56+$0.11 (+1.48%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $7.45

Latest news

Press releaseAug 10, 7:00 AM ETGlobe Newswire
Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency
Press releaseJul 16, 8:00 AM ETGlobe Newswire
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
Press releaseJun 15, 8:00 AM ETGlobe Newswire
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
NewsMay 7, 11:55 AM ET
Grifols Q1 Revenue €1.7 Billion Down From €1.786 Billion YoY
NewsApr 9, 8:08 AM ETAvi Kapoor
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
NewsApr 2, 11:46 AM ET
'Grifols' Canadian License Restricted After Plasma Donor Deaths' - Bloomberg
Press releaseMar 17, 8:28 AM ETGlobe Newswire
Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease
NewsFeb 26, 11:48 AM ET
Grifols Expects Reaching Free Cash Flow Pre-M&A Pre-Dividends Of €500M-575M; 2027 Milestones Unchanged; 2026 Adjusted EBITDA Margin Of Over 25%
NewsJul 9, 11:06 AM ETAvi Kapoor
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Press releaseMay 30, 4:05 PM ETBusiness Wire
Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting
NewsFeb 25, 11:47 AM ET
Grifols Chairman Thomas Glanzmann To Retire; To Be Succeeded Ann-Catherine Berner
Press releaseJan 14, 6:00 AM ETGlobe Newswire
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease
Press releaseJan 13, 10:00 AM ETBusiness Wire
Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols
Press releaseDec 4, 2:30 AM ETBusiness Wire
Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga
NewsDec 2, 3:29 PM ET
'Grifols Shareholder Mason Capital Calls For Board Overhaul' - Bloomberg News
NewsNov 29, 9:29 AM ETVandana Singh
Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?
NewsNov 27, 4:05 PM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsNov 27, 8:16 AM ETAvi Kapoor
Dell, HP, CrowdStrike, 3D Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
NewsNov 19, 4:05 PM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsNov 19, 1:30 PM ET
'Grifols Board Issues Unfavorable Opinion On Brookfield Offer; Brookfield And Grifols Family Have Been In Talks Since July; Investors Are Prepared To Push Back Against Low-Ball Offer' - Bloomberg News
NewsNov 19, 12:21 PM ETAvi Kapoor
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Press releaseNov 19, 8:00 AM ETGlobe Newswire
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
Press releaseNov 19, 2:30 AM ETBusiness Wire
Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors
NewsNov 14, 1:49 PM ET
Reported Earlier, 'Banks To Pitch Roughly €11 Billion Buyout Debt For Grifols; Lenders Expected To Submit Best And Final Offers Next Week; Takeover Deal Likely To Rank Among Biggest In Europe This Year' - Bloomberg News
Press releaseNov 8, 3:54 PM ETBusiness Wire
Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors
Press releaseOct 29, 8:00 AM ETGlobe Newswire
Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Press releaseOct 22, 8:00 AM ETGlobe Newswire
Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
NewsSep 24, 8:51 AM ETAvi Kapoor
Snowflake, Hawaiian Electric Industries And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsAug 25, 4:45 PM ETLekha Gupta
Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
NewsAug 22, 11:16 AM ETAvi Kapoor
Zoom Video Posts Strong Q2 Results, Joins Peloton Interactive, Opera And Other Big Stocks Moving Higher On Thursday
NewsAug 21, 11:32 AM ETVandana Singh
Brookfield Negotiates Over $10B In Debt Financing For Acquisition Of Spanish Pharma Giant Grifols
Press releaseAug 2, 1:21 PM ETBusiness Wire
Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman
Press releaseJul 31, 8:00 AM ETGlobe Newswire
GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339
NewsJul 30, 8:24 AM ET
"Grifols' New Auditor Discovers Non-Cash Accounting Discrepancy Linked To China Stake; Spanish Company To Report Adjustment Related To China Stake; Discrepancy In Reserves Accounting Found By Auditor Deloitte" - Bloomberg News
NewsJul 8, 1:16 PM ETAvi Kapoor
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
NewsJul 8, 11:16 AM ETVandana Singh
Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why
NewsJul 8, 8:38 AM ET
Market-Moving News for July 8th

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency

Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

Grifols Q1 Revenue €1.7 Billion Down From €1.786 Billion YoY

Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

'Grifols' Canadian License Restricted After Plasma Donor Deaths' - Bloomberg

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Grifols Expects Reaching Free Cash Flow Pre-M&A Pre-Dividends Of €500M-575M; 2027 Milestones Unchanged; 2026 Adjusted EBITDA Margin Of Over 25%

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday

Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting

Grifols Chairman Thomas Glanzmann To Retire; To Be Succeeded Ann-Catherine Berner

Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease

Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols

Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga

'Grifols Shareholder Mason Capital Calls For Board Overhaul' - Bloomberg News

Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Dell, HP, CrowdStrike, 3D Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

'Grifols Board Issues Unfavorable Opinion On Brookfield Offer; Brookfield And Grifols Family Have Been In Talks Since July; Investors Are Prepared To Push Back Against Low-Ball Offer' - Bloomberg News

Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors

Reported Earlier, 'Banks To Pitch Roughly €11 Billion Buyout Debt For Grifols; Lenders Expected To Submit Best And Final Offers Next Week; Takeover Deal Likely To Rank Among Biggest In Europe This Year' - Bloomberg News

Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Snowflake, Hawaiian Electric Industries And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?

Zoom Video Posts Strong Q2 Results, Joins Peloton Interactive, Opera And Other Big Stocks Moving Higher On Thursday

Brookfield Negotiates Over $10B In Debt Financing For Acquisition Of Spanish Pharma Giant Grifols

Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339

"Grifols' New Auditor Discovers Non-Cash Accounting Discrepancy Linked To China Stake; Spanish Company To Report Adjustment Related To China Stake; Discrepancy In Reserves Accounting Found By Auditor Deloitte" - Bloomberg News

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why

Market-Moving News for July 8th